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In 1969, Douglas Coleman joined the bodies of an obese and a normal mouse by a procedure
called parabiosis. Days later, the normal mouse starved. Something had taken away its desire to
eat [1]. It was not until almost 25 years later that the true nature of what Coleman then called
"satiety factor" was revealed. In 1994, Jeffrey Friedman identified the adipocytic hormone leptin
[2,3] and it was made official: obesity has a genetic background.
Leptin binds and activates a receptor of the cytokine receptor family. Alternative mRNA
splicing and posttranslational processing result in several receptor isoforms (LRa, LRb, LRc,
LRe, and LRf); the long isoform, LRb, is implicated in signal transduction. The other isoforms
may act as leptin sequesters and transporters, binding leptin without signal transduction. LRb
possesses a long intracellular domain that binds to Janus kinase 2 (JAK2) and to signal trans-
ducers and activators of transcription (STAT)-3 and STAT-5. Plasma leptin crosses the blood–
brain barrier (BBB) via a saturable process, reaching the hypothalamus, where LRb is widely
expressed. Acting in the hypothalamic arcuate nucleus (ARC), leptin inhibits the expression of
orexigenic neuropeptides (e.g., agouti-related protein [AgRP], and neuropeptide Y [NPY]) and
increases the expression of anorexigenic neuropeptides (e.g., proopiomelanocortin [POMC]),
which decreases feeding and increases energy expenditure [4,5].
The role of leptin in human obesity remains poorly understood. Leptin deficiency and
mutations in leptin receptor cause morbid obesity; however, these defects are extremely rare
[6]. On the contrary, the majority of obese humans have high levels of leptin, suggesting leptin
insensitivity or resistance [4]. Central leptin resistance may develop via different mechanisms
(Fig 1), such as (1) impairment in the function of the saturable leptin transporters in the BBB
[7]; (2) deficient leptin signaling [4,5,7,8]; (3) lipotoxicity and endoplasmic reticulum (ER)
stress, as well as (4) inflammatory signals that have also been shown to modulate leptin respon-
siveness [9]. Despite this evidence, recent data questioned that obesity may be a result of leptin
resistance [10].
In a recent publication in PLOS Genetics, Kamal Rahmouni and colleagues describe a novel
mechanism that promotes leptin resistance. They show that neuronal Bardet-Biedl Syndrome
(BBS) proteins influence energy homeostasis through the control of cell surface expression of
the leptin receptor [11]. BBS is a rare and highly pleiotropic autosomal recessive disorder char-
acterized by retinal dystrophy, polydactyly, renal and gonadal anomalies, cognitive
impairment, and obesity [12,13]. BBS is part of an emerging class of diseases named ciliopa-
thies that are characterized by disorders of the cellular cilia, anchoring structures, basal bodies,
or impaired ciliary function [12]. At least 20 genes (BBS1-BBS20), when mutated, lead to defec-
tive cilia and result in BBS [12,13]. Eight of the BBS proteins (BBS1, BBS2, BBS4, BBS5, BBS7,
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BBS8, BBS9, and BBS18) form the stable BBSome complex, which mediates protein trafficking
to the ciliary membrane and, perhaps, to other membrane compartments [12,13].
BBS mouse models recapitulate many of the characteristics found in patients, including obe-
sity, which is associated with hyperphagia and leptin resistance. Notably, some mice showed
altered hypothalamic expression of POMC [14], indicating that the primary effect leading to
positive energy balance might imply altered central leptin action. To address that hypothesis,
Fig 1. The BBsome regulates hypothalamic leptin resistance. Leptin binding to leptin receptor (LRb)
dimmers promotes the phosphorylation of JAK2, which phosphorylates tyrosine residues on the intracellular
part of LRb. Each of these phosphorylated residues recruits an exclusive set of downstream signaling
molecules, such as signal transducers and activators of transcription 3 and 5 (STAT-3 and STAT-5). Leptin
resistance may develop via different mechanisms, such as (1) impairment of the leptin transport in the BBB;
(2) deficient leptin signaling due, for example, to decreased LRb expression, suppressor of cytokine
signaling-3 (SOCS-3), or protein tyrosine phosphatase 1B (PTP1B); (3) lipotoxicity and ER stress; (4)
inflammatory signals; and (5) in a recent issue of PLOS Genetics, Rahmouni and colleagues describe a novel
mechanism that promotes leptin resistance: impaired LRb trafficking to the plasmamembrane in cells due to
defects in the BBSome, a protein complex encoded by genes that, when mutated, cause the Bardet-Biedl
Syndrome (BBS). 3V: third ventricle; ARC: arcuate nucleus of the hypothalamus; DMH; dorsomedial nucleus
of the hypothalamus; LHA: lateral hypothalamic area; PVH: paraventricular nucleus of the hypothalamus;
VMH: ventromedial nucleus of the hypothalamus.
doi:10.1371/journal.pgen.1005980.g001
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Rahmouni and colleagues generated mice with genetic disruption of BBS proteins selectively in
the central nervous system (CNS), in the hypothalamus, and in LRb-expressing cells. The
crossing of Bbs1 floxed with Nestin Cremice led to animals with BBS1 deficiency in the brain,
but not in peripheral tissues. These mice showed an age- and gender-dependent increase in
body weight and adiposity, hyperleptinemia, and hyperphagia, as well as reduced hypothalamic
expression of POMC and decreased energy expenditure. Next, they generated mice models
lacking BB1 protein in LRb-expressing cells by crossing Bbs1 floxed with LRb Cremice. More-
over, they ablated Bbs1 in the mediobasal hypothalamus (MBH) by postnatal virogenetic tar-
geting of Bbs1 floxed mice with adeno-associated viruses encoding Cre. Remarkably, Bbs1 gene
ablation from the LRb-expressing cells or in the MBH was sufficient to cause to obesity in
mice. The coexistence of obesity and hyperleptinemia in Nestincre/Bbsfl/fl and LRbcre/Bbsfl/fl
mice was suggestive of leptin resistance, which was functionally confirmed. The authors also
examined the contribution of obesity to leptin resistance in LRbcre/Bbsfl/fl mice by administer-
ing leptin to calorie-restricted or young (non-obese) animals. Their data showed that both
models exhibit a substantially reduced response to leptin, indicating that leptin resistance in
mice with ablated Bbs1 gene in LRb-expressing cells is not a result of obesity. Further analysis
showed that neither decreased LRb expression nor impaired signaling was the mechanism lead-
ing to leptin resistance.
One important feature of LRbcre/Bbsfl/fl mice was that deletion of the Bbs1 gene did not
impact cilia in LRb cells, suggesting that it did not account for the leptin resistance. To test that
possibility, the authors ablated the intraflagellar transport 88 (Ift88) gene, a key factor for cilio-
genesis [12,13]. The LRbcre/Ift88 fl/fl mice displayed a slight feeding-independent weight gain,
but had a normal response to leptin. This important finding indicated that LRb-independent
mechanisms are involved in the obesity associated with ciliopathies other than BBS. An inter-
esting possibility for leptin resistance could be through BBS protein trafficking [12,13]. By
using in vivo and in vitro models, they demonstrated that knockdown of BBS1 or BBS2, but
not IFT88, reduced the levels of LRb (but not LRa) in the plasma membrane, leading to
decreased leptin signaling. Overall, these data indicate that selective disruption of BBS proteins
impairs the transport of leptin receptor to the plasma membrane, promoting leptin resistance
and obesity (Fig 1) [11].
The significance of these data relates to several novel findings. Firstly, Rahmouni and col-
leagues described a new pathological mechanism leading to obesity, specifically impaired LRb
trafficking in hypothalamic cells and leptin resistance due to defects in the BBSome, indepen-
dently of cilia and obesity. In this sense, although, some data had implicated other cilia-related
proteins in the regulation of energy balance and the participation of leptin signaling was not
fully demonstrated [15]. Secondly, these data change the paradigm that BBS proteins are only
associated with ciliary function because they regulate receptor trafficking through the BBSome
as a mechanism modulating hormonal actions. This idea is also reinforced by recent data dem-
onstrating that disruption of BBS proteins interferes with insulin receptor at the cell surface,
leading to altered glucose metabolism [16]. Thirdly, and more importantly, this evidence pro-
vides the molecular basis for the obesity associated with BBS patients. This is highly relevant.
In fact, there are just a few known examples of primary hypothalamic obesity in humans, such
as hypothalamic injuries [17], and defects in the melanocortin system, such as POMC and
mc4r (melanocortin receptor 4) gene mutants [6].
In summary, the new study of Rahmouni and colleagues establishes the role of disrupted
BBS proteins as a mechanism underlying leptin resistance due to impaired transport of the lep-
tin receptor to the plasma membrane; more importantly, they explain obesity in BBS patients
[11]. Overall, this important information has clear translational repercussions, as it may pro-
vide new strategies to ameliorate some of the symptoms of this devastating disease.
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